Hidden Consequences of Interim Analyses & Adaptive Trial Options
Por um escritor misterioso
Descrição
Guidance on interim analysis methods in clinical trials, Journal of Clinical and Translational Science
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial - The Lancet Oncology
News Archives
Do we need to adjust for interim analyses in a Bayesian adaptive trial design?, BMC Medical Research Methodology
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
Early Treatment with Pegylated Interferon Lambda for Covid-19
New approaches to clinical trials: Adaptive designs - EUPATI Toolbox
Bayesian adaptive designs for multi-arm trials: an orthopaedic case study, Trials
Recent Contributions of Mass Spectrometry-Based “Omics” in the Studies of Breast Cancer
PDF) Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial - The Lancet Haematology
Biomedical Research COVID-19 Impact Assessment: Lessons Learned and Compelling Needs - National Academy of Medicine
Application of Bayesian approaches in drug development: starting a virtuous cycle
de
por adulto (o preço varia de acordo com o tamanho do grupo)
